552 results on '"Faughnan, Marie"'
Search Results
2. Reply to Eker et al. Comment on Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704.
3. An analysis of sex differences in pulmonary arteriovenous malformation presentation, complications and management in a large, multinational registry of patients with hereditary haemorrhagic telangiectasia.
4. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT
5. Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis
6. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
7. Transarterial Embolization of Simple Pulmonary Arteriovenous Malformations: Long-Term Outcomes of 0.018-Inch Coils versus Vascular Plugs
8. Quantification metrics for telangiectasia using optical coherence tomography
9. Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
10. Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations
11. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia
12. Cyclo-oxygenase 2, a putative mediator of vessel remodeling, is expressed in the brain AVM vessels and associates with inflammation
13. Genotype-Phenotype Correlations in Children with HHT.
14. Assessing the Hereditary Hemorrhagic Telangiectasia Algorithms in a Community-Based Patient Population
15. Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
16. Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
17. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
18. Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells
19. Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation
20. Supine vs upright exercise in patients with hepatopulmonary syndrome and orthodeoxia: study protocol for a randomized controlled crossover trial
21. Diagnostic Yield of Rescreening Adults for Pulmonary Arteriovenous Malformations
22. Reperfusion of Pulmonary Arteriovenous Malformations Following Embolotherapy: A Randomized Controlled Trial of Detachable Versus Pushable Coils
23. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
24. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
25. Pre-operative embolization of a complex systemic to pulmonary vascular malformation
26. CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia
27. Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia
28. Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.
29. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: Gene–phenotype correlations
30. Antithrombotic Use Predicts Recanalization of Embolized Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
31. Prevalence and Characteristics of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia.
32. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia
33. An Analysis of Sex Differences in Pulmonary AVM Presentation, Complications, and Management in a Large, Multinational Registry of Patients With HHT
34. Living donor liver transplant between physicians: two viewpoints
35. A theory for polymicrogyria and brain arteriovenous malformations in HHT
36. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
37. Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia (HHT)
38. Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia
39. Neurovascular Complications and Pulmonary Arteriovenous Malformation Feeding Artery Size
40. 88 - Anomalías vasculares pulmonares
41. Cumulative Radiation Dose in Patients With Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations
42. The use of anti-fibrinolytic agents in patients with HHT: a retrospective survey
43. MicroRNA-132-3p, Downregulated in Myeloid Angiogenic Cells from Hereditary Hemorrhagic Telangiectasia Patients, Is Enriched in the TGFβ and PI3K/AKT Signalling Pathways
44. 88 - Pulmonary Vascular Anomalies
45. A framework for applying unfamiliar trial designs in studies of rare diseases
46. Resumption of pulmonary function testing during the COVID-19 pandemic
47. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia
48. Embolization of Pulmonary Arteriovenous Malformations with Amplatzer Vascular Plugs: Safety and Midterm Effectiveness
49. Norfloxacin Therapy for Hepatopulmonary Syndrome: A Pilot Randomized Controlled Trial
50. Embolization for Pulmonary Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia: A Decision Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.